 Westport, CT, May 21, 2021 GLOBE NEWSWIRE -- BioSig Technologies, Inc. Nasdaq: BSGM BioSig or the Company, a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Ken Londoner, Chairman, and CEO of BioSig Technologies, Inc. will present at the Oppenheimer MedTech, Tools Diagnostics Summit on May 26, 2021. The presentation will be available from 8am EST 5pm EST on the conference website Oppenheimer MedTech, Tools, Diagnostics Summit wsw.com . The Company will also be available for one-on-one investor meetings. 